[Controlled clinical study of the therapeutic activity of arginine thiazolidine carboxylate in patients with chronic toxic and postinfective hepatopathies].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001120:Arginine / Q000627:therapeutic use*; D056486:Chemical and Drug Induced Liver Injury / Q000188:drug therapy; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006506:Hepatitis A / Q000188:drug therapy; D006801:Humans; D008107:Liver Diseases / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011897:Random Allocation; D013438:Sulfhydryl Compounds; D013844:Thiazoles / Q000627:therapeutic use*; D053778:Thiazolidines; D008625:Tiopronin / Q000627:therapeutic use
D013438:Sulfhydryl Compounds; D013844:Thiazoles; D053778:Thiazolidines; C020213:arginine thiazolidinecarboxylate; D001120:Arginine; D008625:Tiopronin
Studio clinico controllato dell'attività terapeutica del tiazolidincarbossilato di arginina in pazienti portatori di epatopatie croniche tossiche e postinfettive.